Literature DB >> 21288475

Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity.

Robert E Hampson1, Frances Miller, Guillermo Palchik, Sam A Deadwyler.   

Abstract

Chronic activation or inhibition of cannabinoid receptors (CB1) leads to continuous suppression of neuronal plasticity in hippocampus and other brain regions, suggesting that endocannabinoids may have a functional role in synaptic processes that produce state-dependent transient modulation of hippocampal cell activity. In support of this, it has previously been shown in vitro that cannabinoid CB1 receptors modulate second messenger systems in hippocampal neurons that can regulate operation of intracellular processes including receptors which release calcium from intracellular stores. Here we demonstrate in hippocampal slices a similar endocannabinoid action on excitatory glutamatergic synapses via modulation of NMDA-receptor mediated intracellular calcium levels in confocal imaged neurons. Calcium entry through glutamatergic NMDA-mediated ion channels increases intracellular calcium concentrations by modifying release from ryanodine-sensitive channels in endoplasmic reticulum. The studies reported here show that NMDA-elicited increases in Calcium Green fluorescence are enhanced by CB1 receptor antagonists (i.e., Rimonabant), and inhibited by CB1 agonists (i.e., WIN 55,212-2). Suppression of endocannabinoid breakdown by either reuptake inhibition (AM404) or fatty-acid amide hydrolase inhibition (URB597) produced suppression of NMDA-elicited calcium increases comparable to WIN 55,212-2, while enhancement of calcium release provoked by endocannabinoid receptor antagonists (Rimonabant) was shown to depend on the blockade of CB1receptor mediated de-phosphorylation of Ryanodine receptors. Such CB1 receptor modulation of NMDA elicited increases in intracellular calcium may account for the respective disruption and enhancement by CB1 agents of trial-specific hippocampal neuron ensemble firing patterns during performance of a short-term memory task, reported previously from this laboratory.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21288475      PMCID: PMC3059900          DOI: 10.1016/j.neuropharm.2011.01.039

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  66 in total

1.  Endocannabinoids potentiate synaptic transmission through stimulation of astrocytes.

Authors:  Marta Navarrete; Alfonso Araque
Journal:  Neuron       Date:  2010-10-06       Impact factor: 17.173

2.  The effect of co-administration of the NMDA blocker with agonist and antagonist of CB1-receptor on penicillin-induced epileptiform activity in rats.

Authors:  Duygu Cakil; Mehmet Yildirim; Mustafa Ayyildiz; Erdal Agar
Journal:  Epilepsy Res       Date:  2010-12-21       Impact factor: 3.045

3.  Ionic flow enhances low-affinity binding: a revised mechanistic view into Mg2+ block of NMDA receptors.

Authors:  Ya-Chin Yang; Chia-Hsueh Lee; Chung-Chin Kuo
Journal:  J Physiol       Date:  2009-12-21       Impact factor: 5.182

4.  Lead inhibited N-methyl-D-aspartate receptor-independent long-term potentiation involved ryanodine-sensitive calcium stores in rat hippocampal area CA1.

Authors:  X M Li; Y Gu; J Q She; D M Zhu; Z D Niu; M Wang; J T Chen; L G Sun; D-Y Ruan
Journal:  Neuroscience       Date:  2006-02-02       Impact factor: 3.590

5.  Dual modulation of endocannabinoid transport and fatty acid amide hydrolase protects against excitotoxicity.

Authors:  David A Karanian; Queenie B Brown; Alexandros Makriyannis; Therese A Kosten; Ben A Bahr
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

6.  Protein kinase-dependent phosphorylation and cannabinoid receptor modulation of potassium A current (IA) in cultured rat hippocampal neurons.

Authors:  J Mu; S Y Zhuang; R E Hampson; S A Deadwyler
Journal:  Pflugers Arch       Date:  2000-03       Impact factor: 3.657

7.  Cannabinoids modulate hippocampal memory and plasticity.

Authors:  Hila Abush; Irit Akirav
Journal:  Hippocampus       Date:  2010-10       Impact factor: 3.899

8.  Excitatory afferents to CA3 pyramidal cells display differential sensitivity to CB1 dependent inhibition of synaptic transmission.

Authors:  Mackenzie E Hofmann; Ben Nahir; Charles J Frazier
Journal:  Neuropharmacology       Date:  2008-07-15       Impact factor: 5.250

9.  Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons.

Authors:  Qing Liu; Manjunatha Bhat; Wayne D Bowen; Jianguo Cheng
Journal:  J Pharmacol Exp Ther       Date:  2009-09-14       Impact factor: 4.030

Review 10.  Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis.

Authors:  David R Janero; Alexandros Makriyannis
Journal:  Expert Opin Emerg Drugs       Date:  2009-03       Impact factor: 4.191

View more
  23 in total

1.  Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase - dual targets of the endocannabinoid system to protect against seizure pathology.

Authors:  Vinogran Naidoo; David A Karanian; Subramanian K Vadivel; Johnathan R Locklear; JodiAnne T Wood; Mahmoud Nasr; Pamela Marie P Quizon; Emily E Graves; Vidyanand Shukla; Alexandros Makriyannis; Ben A Bahr
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

2.  Endocannabinoids exert CB1 receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat protein.

Authors:  Changqing Xu; Douglas J Hermes; Blessing Nwanguma; Ian R Jacobs; Kenneth Mackie; Somnath Mukhopadhyay; Aron H Lichtman; Bogna Ignatowska-Jankowska; Sylvia Fitting
Journal:  Mol Cell Neurosci       Date:  2017-07-19       Impact factor: 4.314

3.  Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDS.

Authors:  Douglas J Hermes; Changqing Xu; Justin L Poklis; Micah J Niphakis; Benjamin F Cravatt; Ken Mackie; Aron H Lichtman; Bogna M Ignatowska-Jankowska; Sylvia Fitting
Journal:  Neuropharmacology       Date:  2018-08-13       Impact factor: 5.250

4.  Neuroanatomical correlates of the inhibition of tremulous jaw movements in rats by a combination of memantine and Δ9 -tetrahydrocannabinol.

Authors:  Ilya D Ionov; Irina I Pushinskaya; David D Frenkel; Niсholas P Gorev; Larissa A Shpilevaya
Journal:  Br J Pharmacol       Date:  2020-01-24       Impact factor: 8.739

5.  Interaction between NMDA and CB2 function in the dorsal hippocampus on memory consolidation impairment: an isobologram analysis.

Authors:  Mohammad Nasehi; Marziyeh Hajikhani; Mohaddeseh Ebrahimi-Ghiri; Mohammad-Reza Zarrindast
Journal:  Psychopharmacology (Berl)       Date:  2016-11-17       Impact factor: 4.530

Review 6.  Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol.

Authors:  Douglas L Boggs; Jacques D Nguyen; Daralyn Morgenson; Michael A Taffe; Mohini Ranganathan
Journal:  Neuropsychopharmacology       Date:  2017-09-06       Impact factor: 7.853

7.  Memory encoding in hippocampal ensembles is negatively influenced by cannabinoid CB1 receptors.

Authors:  Robert E Hampson; Andrew J Sweatt; Anushka V Goonawardena; Dong Song; Rosa H M Chan; Vasilis Z Marmarelis; Theodore W Berger; Sam A Deadwyler
Journal:  Behav Pharmacol       Date:  2011-08       Impact factor: 2.293

Review 8.  Marijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalization.

Authors:  Delphine Psychoyos; K Yaragudri Vinod
Journal:  Drug Test Anal       Date:  2012-08-13       Impact factor: 3.345

9.  Hippocampal Gαq/₁₁ but not Gαo-coupled receptors are altered in aging.

Authors:  Joseph A McQuail; Kathleen N Davis; Frances Miller; Robert E Hampson; Samuel A Deadwyler; Allyn C Howlett; Michelle M Nicolle
Journal:  Neuropharmacology       Date:  2013-01-21       Impact factor: 5.250

10.  Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate.

Authors:  Pilar Sánchez-Blázquez; María Rodríguez-Muñoz; Ana Vicente-Sánchez; Javier Garzón
Journal:  Antioxid Redox Signal       Date:  2013-06-01       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.